The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis

Muscle and Nerve

Volumn 22, Issue 12, 1999, Pages 1704-1709

  Miyamoto, Katsuichi ^a   Oka, Nobuyuki ^a   Kawasaki, Teruaki ^a   Satoi, Hitoshi ^a   Matsuo, Akinori ^a   Akiguchi, Ichiro ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

COX 2; COX 2 inhibitor; Experimental allergic neuritis; Neuropathy; Prostaglandin

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; NIMESULIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ALLERGIC NEUROPATHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; GENE EXPRESSION; IMMUNE MEDIATED INJURY; NERVE DEGENERATION; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LIPOXYGENASE INHIBITORS; MALE; MOVEMENT; NERVE FIBERS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED LEW; SCIATIC NERVE; SCIATIC NEUROPATHY; SULFONAMIDES;

EID: 0032758910     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199912)22:12<1704::AID-MUS13>3.0.CO;2-A     Document Type: Article

References (25)

1. Bilodeau JF, Wang M, Chung FL, Castonguay A. Effect of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice. Free Radic Biol Med 1995;18:47-57.
2. Brain SD, Williams TJ. Leukotrienes and inflammation. Pharmacol Ther 1990;46:57-66.
3. Dewitt D, Smith WL. Yes, but do they still get headaches? Cell 1995;83:345-348.
4. Elder DJ, Paraskeva C. Cox-2 inhibitors for colorectal cancer. Nat Med 1998;4:392-393.
5. Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40: 197-210.
6. Hartung HP, Schafer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Brain 1988;111:1039-1059.
7. Hartung HP, Stoll G, Toyka KV. Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy, 3rd ed. Philadelphia: Saunders; 1993. p 418-444.
8. Higgs GA. The effects of lipoxygenase inhibitors in anaphylactic and inflammatory responses in vivo. Prostagland Leukot Med 1984;13:89-92.
9. Kawasaki T, Oka N, Saida T, Hirota N, Kaji R, Ohta M, Akiguti I, Kimura J. Histopathological and electrophysiological findings in experimental allergic neuritis induced by a synthetic peptide of human myelin P2 protein. Electroencephalogr Clin Neurophysiol 1995;97(suppl):S223.
10. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990; 323:645-655.
11. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthrilis.J Rheumatol 1997;24(suppl 49):9-14.
12. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86:1375-1379.
13. Miyamoto K, Oka N, Kawasaki T, Satoi H, Akiguchi I, Kimura J. The effect of cyclooxygenase-2 inhibitor on experimental allergic neuritis. NeuroReport 1998;9:2331-2334.
14. Nakatsuji S, Terada N, Yoshimura T, Horie Y, Furukawa M. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats. Prostaglandins 1996;55:395-402.
15. Sairanen T, Ristamaki A, Lindsberg MLK, Paetau A, Kaste M, Lindsberg PJ. Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol 1998;43:738-747.
16. Satoi H, Oka N, Kawasaki T, Miyamoto K, Akiguchi I, Kimura J. Mechanisms of tissue injury in vasculitic neuropathies. Neurology 1998;50:492-496.
17. Schwalm SF, Lewis AJ, Hand JM. Inhibition of leukotriene-induced contraction of guinea pig trachea by 5-lipoxygenase inhibitor. Prostaglandins 1987;33:113-119.
18. Simmons RD, Hugh AR, Willenborg DO, Cowden WB. Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Acta Neurol Scand 1992;85:197-199.
19. Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997;216:201-210.
20. Taniguti Y, Ikesue A, Yokoyama K, Noda K, Debuchi H, Nakamura T, Toda A. Selective inhibition by nimesulide, a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in-vitro. Pharm Sci 1995;1: 173-175.
21. Tavares IA, Bishai PM, Bennet A. Activity of Nimesulide on constitutive and inducible cyclooxygenases. Drug Res 1995; 45:1093-1095.
22. Vane JR, Mitchell JA, Appleton L, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitricoxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-2050.
23. Wakita H, Tomimoto H, Akiguchi I, Lin JX, Miyamoto K, Oka N. A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. NeuroReport 1999;10: 1461-1465.
24. Weishaupt A, Gold R, Gaupp S, Giegerich G, Hartung HP, Toyka KV. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc Natl Acad Sci USA 1997;94:1338-1343.
25. Zettl UK, Gold R, Toyka KV, Hartung HP. Intravenous glucocorticosteroid treatment augment apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J Neuropathol Exp Neurol 1995;54:540-547.